1Bolis G,Searfone G,Giardina G,et al.Carboplatin alone vs earboplatin plus epidoxorubiein as second-line therapy for eisplatin- or earboplatin-sensitive ovarian cancer. Gyneeol Oneol,2001,81:3-9.
2Ozols-Robert F. Recurrent ovarian cancer:evidence-based treatment.J Clin Onco1,2002,20(5): 1161-1163.
3Zanotti KM,Bilinson JL,Kennedy AW, et al.Treament of relapsed carcinoma of the ovary with single -agent paclitaxel following exposure to paclitaxel and platinum employed as initial therapy. Gynecol 0ncol,2000,79:211-215.
4Cantus MG, Buda A, Parma G, et al.Randomized controlled trial of single-agent paclitaxel versus cyclophosphamide,doxorubicin,and cisplatin in patients with recurrent ovarian cancer who responded to first-line platinum-based regimens. J Clin Oncol,2002,20:1232-1237.
5Ledermann JA,on behalf of ICON and AGO Collaborators. Randomized trim of paclitaxel in combination with platinum chemotherapy versus platinum-based chemotherapy in the treatment of relapsed ovarian cancer(ICON4/OVAR2.2). Proc Am Soc Clin Oncol 2003,22:446.Abstract 1794.
6McGuire WP,Blessing JA,Bookman MA, et al. Topotecan has substantial antitumor acticity as first-line salvage therapy in platinum-sensitive ovarian cancer :a Gynecologic Oncology Group Study. J Clin Oncol, 2000,18(5): 1062-1067.
7Bookman MA, Malmstrom H, Bolis G,et al. Topotecan for the treatment of advanced epithelial ovarian cancer: an open-label phase Ⅱ study in patients treated after prior chemotherapy that contained cisplatin or carboplatin and paclitaxel. J Clin Oncol, 1998,16(10):3345-3352.
8Bookman MA.Developmental chemotherapy in advanced ovarian cancer: incorporation of newer cytotoxic agents in a phase Ⅲ randomized trial of the Gynecologic Oncology Group (GOG-0182). Semin Oncol,2002,29[ 1 Suppl 1]:20-31.
9Morris R,Alvarez RD, Andrews S,et al. Topotecan weekly bolus chemotherapy for potentially chemosensitive relapsed ovarian and peritoneal cancer-An update. Proc Am Soc Clin Oncol, 2003,22:446.Abstract 1846.
10Katsumata N,Tsunematsu R,Tanaka K, et al.A phase Ⅱ trial of doc-etaxel in platinum pre-treated patients with advanced epithelial ovarian cancer:a Japanese cooperative study.Ann Oncol ,2000,11 (12):1531-1536.
